Divergent effects of TNFα in the adoptive immunotherapy of a murine sarcoma

This publication has 17 references indexed in Scilit:

• Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction
  New England Journal of Medicine, 1990
• Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes.
  The Journal of Immunology, 1989
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988
• Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
  The Journal of Immunology, 1988
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.
  The Journal of Immunology, 1987
• Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.
  The Journal of Immunology, 1986
• Tumor Necrosis Factor (TNF)
  Science, 1985
• Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.
  The Journal of Immunology, 1984
• Passive Immunotherapy of Cancer in Animals and Man
  Published by Elsevier ,1977